Concepedia

George Giotopoulos

GG

31

Publications

3.6K

Citations

24

H-Index

2006

Active since

Affiliations

Wellcome/MRC Cambridge Stem Cell Institute(Current)

University of Cambridge

Wellcome Sanger Institute

Addenbrooke's Hospital

Medical Research Council

George Giotopoulos is an author at Wellcome/MRC Cambridge Stem Cell Institute specializing in cell biology, medicine, and chromatin.

ORCID

Top concepts

Publications per year

2006–2025

31

Publications

31

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

Mark A. Dawson, Rab K. Prinjha, Antje Dittmann et al. · Nature · 2011 · 1.5K citations · Full text

, , +11

BET inhibitor resistance emerges from leukaemia stem cells

Chun Yew Fong, Omer Gilan, Enid Y.N. Lam et al. · Nature · 2015 · 542 citations · Full text

, , +5

Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia

Mark A. Dawson, Emma Gudgin, Sarah J. Horton et al. · Leukemia · 2013 · 173 citations · Full text

Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition

Paolo Gallipoli, George Giotopoulos, Konstantinos Tzelepis et al. · Blood · 2018 · 148 citations · Full text

The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes

George Giotopoulos, R.P. Symonds, K. Foweraker et al. · British Journal of Cancer · 2007 · 118 citations · Full text

Rows per page

1–5 of 31